Similar articles

• Neocarzinostatin: report of a phase II clinical trial.

  McKelvey EM, Murphy W, Zander A, Bodey GP. McKelvey EM, et al. Cancer Treat Rep. 1981 Jul-Aug;65(7-8):699-701. Cancer Treat Rep. 1981. PMID: 6454486 Clinical Trial.
• [Treatment of acute leukemia with neocarzinostatin (NCS)].

  Masaoka T, Nakamura H, Hasegawa Y, Shibata H, Tatsumi N. Masaoka T, et al. Rinsho Ketsueki. 1974 Dec;15(12):1309-16. Rinsho Ketsueki. 1974. PMID: 4282747 Japanese. No abstract available.
• [The clinical evaluation of a new antileukemic agent. 2) Neocarzinostatin (author's transl)].

  Kitajima K. Kitajima K. Nihon Ketsueki Gakkai Zasshi. 1974 Oct;37(5):767-72. Nihon Ketsueki Gakkai Zasshi. 1974. PMID: 4282818 Japanese. No abstract available.
• Neocarzinostatin in cancer chemotherapy (review).

  Maeda H. Maeda H. Anticancer Res. 1981;1(3):175-86. Anticancer Res. 1981. PMID: 6211130 Review.
• Zinostatin (neocarzinostatin).

  Issell BF, Prestayko AW, Comis RL, Crooke ST. Issell BF, et al. Cancer Treat Rev. 1979 Dec;6(4):239-49. doi: 10.1016/s0305-7372(79)80040-7. Cancer Treat Rev. 1979. PMID: 161199 Review. No abstract available.